Insulin: cost sharing under health insurance policies and plans capped -
AB584Insulin: cost sharing under health insurance policies and plans capped -
SB574Insulin safety net programs created, reports required [Sec. 3090] -
AB43Insulin safety net programs created, reports required [Sec. 3090] [original bill only] -
SB70MA payment for puberty-blocking drugs or gender reassignment surgery prohibited [S.Sub.Amdt.2: Sec. 308-311] -
SB70Medical aid in dying provisions created; JRCCP may report -
AB781Medical aid in dying provisions created; JRCCP may report -
SB739Medical cannabis program created; Office of Medical Cannabis Regulation created in DHS; grower, producer, and testing laboratory licenses ; patient and caregiver registry; dispensaries, prescription drug monitoring program, child placement and custody, fair employment law, UI, WC, open housing law, sales tax exemption, and criminal penalty provisions; reports from JRCCP, JSCTE, and DOA -
AB1040Medicinal psilocybin treatment on patients with PTSD: pilot program at UW Madison established; trust fund and FDA provisions -
AB753Medicinal psilocybin treatment on patients with PTSD: pilot program at UW Madison established; trust fund and FDA provisions -
SB727Naloxone or other opioid antagonist: court can order criminal defendant to pay law enforcement agency’s costs for administration of -
AB1058Naloxone or other opioid antagonist: court can order criminal defendant to pay law enforcement agency’s costs for administration of -
SB974Opioid antagonist: funding to entities for purchase of [Sec. 802] -
AB43Opioid antagonist: funding to entities for purchase of [Sec. 802] [original bill only] -
SB70Opioid antagonist supply available in public schools and independent charter schools required [Sec. 2121, 2122] -
AB43Opioid antagonist supply available in public schools and independent charter schools required [A.Sub.Amdt.1: further revisions, provisions changed to civil liability exemption for administering an opioid antagonist re elementary and secondary schools] -
AB223Opioid antagonist supply available in public schools and independent charter schools required [Sec. 2121, 2122] [original bill only] -
SB70Opioid antagonist supply available in public schools and independent charter schools required -
SB206Pharmacy benefit managers: revisions to regulations, pharmaceutical product reimbursements, drug formularies, pharmacy networks, audits, fiduciary and disclosure requirements, application of prescription drug payments, discriminatory reimbursement of 340B entities, and retaliation for reporting alleged violations -
AB773Pharmacy benefit managers: revisions to regulations, pharmaceutical product reimbursements, drug formularies, pharmacy networks, audits, fiduciary and disclosure requirements, application of prescription drug payments, discriminatory reimbursement of 340B entities, and retaliation for reporting alleged violations -
SB737Prescription Drug Affordability Review Board created; Office of Prescription Drug Affordability created in OCI, FTE positions -
AB747Prescription Drug Affordability Review Board created; Office of Prescription Drug Affordability created in OCI, FTE positions -
SB718Prescription Drug Affordability Review Board created [Sec. 64, 76, 3042-3045, 9123 (1), 9423 (1)] -
AB43Prescription Drug Affordability Review Board created [Sec. 64, 76, 3042-3045, 9123 (1), 9423 (1)] [original bill only] -
SB70Prescription drug cost reporting by manufacturers: requirements established -
AB1134Prescription drug cost reporting by manufacturers: requirements established -
SB1032Prescription drug importation program established; JCF approval required [Sec. 3040, 9123 (2)] -
AB43Prescription drug importation program established; JCF approval required [Sec. 3040, 9123 (2)] [original bill only] -
SB70Pupils who have asthma: schools required to adopt a management plan which includes standing orders for short-acting bronchodilators; advanced practice nurse prescriber, physician assistant, and physician provisions and civil liability immunity -
AB914Pupils who have asthma: schools required to adopt a management plan which includes standing orders for short-acting bronchodilators; advanced practice nurse prescriber, physician assistant, and physician provisions and civil liability immunity -
SB854Ready-to-use glucagon rescue therapies: prescriptions and standing orders to public, private, and tribal schools from specified medical personnel; administration by school personnel; civil liability immunity -
AB450Ready-to-use glucagon rescue therapies: prescriptions and standing orders to public, private, and tribal schools from specified medical personnel; administration by school personnel; civil liability immunity [S.Amdt.1: changed to "undesignated glucogon," definitions revised] -
SB447SeniorCare participants allowed to purchase 100-day prescription drug supplies; rule revision and DHS to apply for federal Medicaid waiver [Admin.Code DHS 109.31] -
AB259SeniorCare participants allowed to purchase 100-day prescription drug supplies; rule revision and DHS to apply for federal Medicaid waiver [Admin.Code DHS 109.31] -
SB263Serious mental illness treatment: DHS prohibited from imposing utilization management controls for certain prescription drugs under the MA program -
AB654Serious mental illness treatment: DHS prohibited from imposing utilization management controls for certain prescription drugs under the MA program -
SB618State prescription drug purchasing entity study [Sec. 9123 (4)] -
AB43State prescription drug purchasing entity study [Sec. 9123 (4)] [original bill only] -
SB70Step therapy protocol for certain cancer drugs: insurer, pharmacy benefit manager, or utilization review organization prohibited from requiring -
AB836Step therapy protocol for certain cancer drugs: insurer, pharmacy benefit manager, or utilization review organization prohibited from requiring -
SB807Value-based diabetes medication pilot project [Sec. 3039] -
AB43Value-based diabetes medication pilot project [Sec. 3039] [original bill only] -
SB70Value-based purchasing arrangements under MA: DHS may enter into with a drug manufacturer -
AB687Value-based purchasing arrangements under MA: DHS may enter into with a drug manufacturer -
SB672Demolition of abated former drug dwellings: appropriation for reimbursements to DMA [Sec. 477] -
AB43Demolition of abated former drug dwellings: appropriation for reimbursements to DMA [Sec. 477] [original bill only] -
SB70First-degree reckless homicide re certain controlled substances: felony penalty changes; JRCCP may report -
AB68First-degree reckless homicide re certain controlled substances: felony penalty changes; JRCCP may report -
SB101Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent [Sec. 3334-3336] -
AB43Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent -
AB634Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent [Sec. 3334-3336] [original bill only] -
SB70Immunity from prosecution for controlled substance possession for person aiding an overdose victim: 2017 WisAct 33 expired provisions made permanent -
SB595Indoor smoking ban applied to electronic smoking devices and marijuana; “smoking” definition revised -
AB1062Kratom products made from the leaf of the Mitragyna speciosa plant: manufacture, distribution, delivery, and possession regulated -
AB393Kratom products made from the leaf of the Mitragyna speciosa plant: manufacture, distribution, delivery, and possession regulated -
SB445Marijuana legalization: recreational use amount limited; production, processing, and selling permit; medical marijuana registry; drug screening and testing; employment discrimination; excise tax and community reinvestment fund provisions; JRCCP may report; JSCTE appendix report; JLC study [Sec. 267, 268, 419, 523, 537, 598, 1023, 1128, 1156, 1157, 1174, 1180, 1544, 1602, 1730-1732, 1735, 1896, 1898, 1925, 1926, 1942, 2023, 2024, 2043, 2294, 2319, 2320, 2581, 2666, 2786, 3317, 3319-3323, 3325-3333, 3341, 3343-3349, 3355, 3356, 3362-3365, 3374, 9128 (1)] -
AB43Marijuana legalization: recreational use amount limited; production, processing, and selling permit; medical marijuana registry; drug screening and testing; employment discrimination; equity grants; excise tax; law enforcement training program; JRCCP may report; JSCTE appendix report -
AB506Marijuana legalization: recreational use amount limited; production, processing, and selling permit, medical marijuana registry; drug screening and testing; employment discrimination; excise tax and community reinvestment fund provisions; JRCCP may report; JSCTE appendix report; JLC study [Sec. 267, 268, 419, 523, 537, 598, 1023, 1128, 1156, 1157, 1174, 1180, 1544, 1602, 1730-1732, 1735, 1896, 1898, 1925, 1926, 1942, 2023, 2024, 2043, 2294, 2319, 2320, 2581, 2666, 2786, 3317, 3319-3323, 3325-3333, 3341, 3343-3349, 3355, 3356, 3362-3365, 3374, 9128 (1)] [original bill only] -
SB70Marijuana legalization: recreational use amount limited; production, processing, and selling permit; medical marijuana registry; drug screening and testing; employment discrimination; equity grants; excise tax; law enforcement training program; JRCCP may report; JSCTE appendix report -
SB486Marijuana possession or distribution: penalty for no more than 28 grams eliminated; distributing to a minor and ordinance provisions -
AB1207Marijuana possession or distribution: penalty for no more than 28 grams eliminated; distributing to a minor and ordinance provisions -
SB1113Marijuana possession penalties changed, local ordinance and drug paraphernalia provisions; employer liability for not drug testing employees or prospective employees; JRCCP may report -
AB861Medical cannabis program created; Office of Medical Cannabis Regulation created in DHS; grower, producer, and testing laboratory licenses ; patient and caregiver registry; dispensaries, prescription drug monitoring program, child placement and custody, fair employment law, UI, WC, open housing law, sales tax exemption, and criminal penalty provisions; reports from JRCCP, JSCTE, and DOA -
AB1040Pill tableting or pill encapsulation devices: possession, delivery, or manufacturing of prohibited; exceptions provided; JRCCP may report -
AB1011Pill tableting or pill encapsulation devices: possession, delivery, or manufacturing of prohibited; exceptions provided; JRCCP may report -
SB931Xylazine testing materials excluded from drug paraphernalia definition; civil and criminal liability exemption for distributing and administering testing products -
AB950Xylazine testing materials excluded from drug paraphernalia definition; civil and criminal liability exemption for distributing and administering testing products -
SB875Driver improvement surcharge [S.Amdt.13 to S.Sub.Amdt.2: Sec. 460g, m, 9344 (2m), 9444 (1m)] -
SB70Homicide by intoxicated use of a vehicle: restitution order considerations re each minor child of the victim -
AB87Homicide by intoxicated use of a vehicle: restitution order considerations re each minor child of the victim -
SB87Ignition interlock device requirement applied to all OWI offenses involving alcohol [Sec. 2767, 9344 (2)] -
AB43Ignition interlock device requirement applied to all OWI offenses involving alcohol -
AB1132Ignition interlock device requirement applied to all OWI offenses involving alcohol [Sec. 2767, 9344 (2)] [original bill only] -
SB70Ignition interlock device requirement applied to all OWI offenses involving alcohol -
SB1044Ignition interlock restricted driver’s license created -
AB167Ignition interlock restricted driver’s license created -
SB150Safe ride program surcharge increased; municipalities to provide information about the program to retailers -
AB304Safe ride program surcharge increased; municipalities to provide information about the program to retailers -
SB332